AbCellera Biologics Inc.ABCLNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank29
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Percentile
P29
Within normal range
vs 5Y Ago
-1.4x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2025$-217.10M+31.0%
2024$-314.77M-32.7%
2023$-237.21M-209.6%
2022$216.51M+5.9%
2021$204.41M+31.0%
2020$156.03M+3889.9%
2019$-4.12M-446.7%
2018$-753000.00-